Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families
Launched by HOSPITAL AUTHORITY, HONG KONG · Aug 21, 2019
Trial Information
Current as of June 23, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Service users
- • Diagnosis of schizophrenia-spectrum disorders, based on clinical judgement by the treating clinicians
- • Aged 18-65
- • Able to communicate in Cantonese
- • Family caregivers
- • Aged above 18
- • Living with service users
- • Able to communicate in Cantonese
- • Nominated by the service users
- Exclusion Criteria:
- • Service users
- • Having co-morbidity of learning disability
- • Organic/neurological conditions
- • Substance misuse disorder
- • Family caregivers
- • Having active psychiatric conditions
- • Looking after more than one family member suffering from chronic physical or mental illnesses
About Hospital Authority, Hong Kong
The Hospital Authority of Hong Kong is a statutory body responsible for managing the public healthcare system in Hong Kong. Established in 1990, it oversees a network of public hospitals and clinics, delivering comprehensive medical services to the community. The authority is committed to advancing medical research and innovation, facilitating clinical trials that aim to improve patient care and health outcomes. With a focus on ethical standards and regulatory compliance, the Hospital Authority collaborates with local and international research institutions to enhance the quality of healthcare through evidence-based practices and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Chak Fai Ma, MSc
Principal Investigator
Kwai Chung Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials